India News | Reported by Sukirti Dwivedi, Edited by Anindita Sanyal | Monday January 4, 2021
Two vaccines for coronavirus, Oxford University's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator on Sunday. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe," Drug Controller G...
www.ndtv.com